MedPath

Interventions Made to Preserve Cognitive Function

Not Applicable
Terminated
Conditions
ESRD
Interventions
Other: Cognitive training
Other: Exercise training
Other: Combined cognitive and exercise training
Registration Number
NCT03616535
Lead Sponsor
Johns Hopkins University
Brief Summary

This is a randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD). The investigators will test three interventions cognitive training (CT), exercise training (ET), and combined cognitive and exercise training (CT+ET) relative to standard of care (SC).

Detailed Description

This will be a two by two factorial, randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD). The investigators primary objective is to determine if receiving cognitive training (tablet-based brain games), exercise training (stationary foot pedal), or combined cognitive and exercise training preserves executive function relative to those with standard of care . The secondary objectives are to compare the rates of end stage renal disease (ESRD)-specific clinical outcomes and patient centered outcomes among those receiving CT, or ET, or CT+ET relative to those in SC. The investigators will formally test whether receiving CT or ET will preserve executive function and receiving combined CT+ET will preserve executive function better than CT or ET alone.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • 18 years or older at enrollment
  • English speaking
  • within 3 months to 3 years of initiating hemodialysis
  • receiving hemodialysis at participating dialysis centers
Exclusion Criteria

Patients with the following conditions will be excluded:

  • Pregnancy
  • Angina Pectoris
  • Chronic lung disease requiring oxygen
  • Musculoskeletal conditions that limit mobility
  • Upper or lower extremity amputation
  • Orthopedic disorders exacerbated by physical activity
  • Femoral arteriovenous (AV) access
  • Hepatitis B infection
  • Blindness/Legal blindness

In addition to conditions outlined above, patients who are currently incarcerated will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Cognitive trainingCognitive trainingParticipants randomized to CT will play "brain games" on a tablet. They will be asked to engage in the activity for a minimum of 30 minutes during each hemodialysis session for 6 months. At each HD session, participants will have 10 different brain games to play and the games will vary for each session.
Exercise trainingExercise trainingParticipants randomized to the ET arm will be given a stationary foot peddler and will be asked to engage in the activity for a minimum of 30 minutes at each hemodialysis session for 6 months. ET will start with a 2 minute warm up, then the resistance will be adjusted so that participants are working at perceived exertion of "somewhat strong," using the Borg scale (87) (\~50 rpm). Resistance will be increased when the rating falls below "somewhat hard."
Combined cognitive and exercise trainingCombined cognitive and exercise trainingParticipants in the CT+ET arm will start with 30 minutes of CT (playing "brain games" on tablet) with a 15-minute break, and then, 30 minutes of ET (stationary foot peddler).
Primary Outcome Measures
NameTimeMethod
Change in Executive Function as Assessed by the Trail Making Test Assessment (TMT)3 months

Change in executive function between baseline and 3 months as assessed by the Trail Making Test which is comprised of Part A and Part B. Executive function is assessed by the time (seconds) to complete Part B minus the time (seconds) to complete Part A. Needing more time to complete the test indicates worse executive function.

Secondary Outcome Measures
NameTimeMethod
Number of Hospitalizations12 months

The number of hospitalizations parameterized as both the number of hospital admissions and number of days hospitalized during the 6 months of interventions and 6 months after the interventions

Mortality18 months

Mortality will be captured through Center for Medicare and Medicaid Services (CMS) death notification or the National Death Index. Mortality will be ascertained within the 6 months of the intervention and 1 year after the intervention (1.5 years total).

Number of Falls12 months

Number of injurious falls resulting in a medical encounter during the 6 months of interventions and for 6 months after the interventions

Change in Global Cognitive Function as Measured by the Montreal Cognitive Assessment (MoCA)3 months and 6 months

Change in global cognitive function at 3-months and 6 months of interventions as measured by the Montreal Cognitive Assessment (MoCA). It is a brief 30 question test that assesses different cognitive domains: attention and concentration, executive functions, memory, language, visual construction skills, conceptual thinking, calculations, and orientation. Total possible score is 30 points and a score of 26 or above is considered normal.

Change in Executive Function as Measured by the Stroop Test3 months and 6 months

Change in executive function at 3 months and 6 months of interventions as measured by the Stroop Test. The Stroop test is a screening test for cognitive function test and evaluates the inhibitory control of executive function. It is a measure of the ability of the brain to sort out distracting or unnecessary information from the meaningful tasks. It involves reading the name of a color printed in a different color ink. The time ratio of color-word interference and color only tasks will be calculated.

Change in Executive Function as Measured by the Digit Symbol Substitution Test3 months and 6 months

Change in executive function at 3 months and 6 months of interventions as measure by the Digit Symbol Substitution Test. This test evaluates the speed and working memory components of executive function. It involves a key consisting of the numbers 1-9, each paired with a unique, easy-to--draw symbol such as a "V", "+" or "\>". Below the key are a series of the numbers 1-9 in random order and repeated several times. The participant is allowed 90 seconds to fill in the corresponding symbol for each number. This task requires the individual to visually scan the answer key provided at the top of the test and then write the correct symbol by each number as quickly as possible. The correct number of symbols written within 90 seconds is measured.

Change in Physical Function as Measured by the Short Physical Performance Battery (SPPB) Test3 months and 6 months

Change in lower extremity function at 3 months and 6 months of interventions using the SPPB test. The SPPB is an objective assessment tool for evaluating lower extremity functioning This test is a performance-based assessment comprised of 3 tasks: 1) repeated chair stands, 2) standing balance, and 3) a 4-meter usual paced walk in those with and without a walking aid (meters/second). Participants receive a score of 0 for a task if they were unable to complete the task; otherwise, they receive scores of 1-4 based on population-based norms. The scores of the three tasks are summed to create the SPPB score. The SPPB score ranges from 0 to 12, with lower scores indicating poorer function.

Change in Patient-centered Outcomes as Measured by the Kidney Disease Quality of Life (KDQOL) Survey3 months and 6 months

Change in kidney disease-specific physical and mental quality of life at 3 months and 6 months of interventions. The KDQOL s a kidney disease-specific measure of how kidney disease is impacting a participant's quality of life. It is a 36-item survey with 3 subscales including physical and mental health-related quality of life, and kidney disease-specific HRQOL. Each subscale is scored 0 to 100 with higher scores indicating better HRQOL.

Change in Patient-centered Outcomes as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)-293 months and 6 months

Change in the participants' physical, mental, and social health status at 3 months and 6 months of interventions. PROMIS-29 is a health-related quality of life survey which assesses each of the 7 PROMIS domains with 4 questions. Norm-based scores have been calculated for each domain on the PROMIS measures. High scores represent more of the domain being measured. Thus, on symptom-oriented domains of PROMIS-29 (anxiety, depression, fatigue, pain interference, and sleep disturbance), higher scores represent worse symptomatology. On the function-oriented domains (physical functioning and social role) higher scores represent better functioning.

Number of Amputations12 months

The number of amputations during the 6 months of interventions and 6 months after interventions. This information will be either self-reported by the participant or abstracted from the medical records to see if the interventions are associated with amputations

Number of Participants Able to Return to Work12 months

The number of participants able to return to work during the 6 months of interventions and 6 months after interventions.

Trial Locations

Locations (2)

Johns Hopkins School of Medicine

🇺🇸

Baltimore, Maryland, United States

New York University Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath